Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
CNO Financial Group, Inc.
CNO
NYSE·Financial Services·Insurance - Life·Mkt cap $4.9B
$52.43
▲ +0.69%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$35.24 - $53.03
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 37.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Specialized expertise in senior and middle-income insurance markets with 45+ year operating history
- Multi-brand portfolio (Bankers Life, Washington National, Colonial Penn) enabling targeted market segmentation
- Diversified distribution channels including direct marketing, agents, and worksite sales reducing customer acquisition concentration
- Established relationships with independent producers and employer groups creating switching costs
- Focused product development addressing specific needs of 50+ demographic with limited direct competition in niche segments
Bear Case
1 risk
- Average volatility.
Growth
Mild headwinds expected
Aging U.S. population increasing demand for Medicare supplement and long-term care insurance products
Value
Fairly valued vs Life Insurance peers
Momentum
Hot
+26.5% over 3m
Quality
Strong
Excellent business quality
Dividend
Modest
1.33% yield
Smart-money signal
Who's buying CNO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 27, 2026
APR 30, 2026
Reported EPS of $1.29 vs $0.91 consensus (+41.8% surprise). Revenue of $1.0B vs $1.0B expected (+2.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+41.8%
Next: Apr 27, 2026
Revenue trend · last 8Q
—
—
-6%
-14%
+9%
+7%
+10%
+3%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$1.0B
$1.1B
$1.0B
$1.0B
$1.2B
$1.2B
$1.1B
$1.0B
Margins · last 8Q
Gross
—
Operating
—
Profit
3.7%
Wall Street consensus
2 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
$48.00
▼ -8.4% vs $52.43
Latest: Evercore · $48.00 · Jun 1, 2026
1 analyst covering